Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mark A. Stang who wrote (7204)	4/17/1998 10:10:00 AM
From: Don Dunlap	Respond to of 23519

Gap Down - Great!! Another buying opportunity. Quadrulple UP! Now probably would be the worst time to sell. IMS data is the best news I have heard in a while, if it is accurate. A few more weeks should tell. Not much left to lose on this, so hanging in there. Even 15 in a year would cut the loss significantly.

To: Mark A. Stang who wrote (7204)	4/17/1998 10:40:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

Mark, Glad to see your back. One quick post before I go. I think it's great news that Viagara sales are soaring. This means that the ED market may be bigger than expected. The faster the ED patients enter the market the greater the spill over to Muse. To bad those nitwits managing Vivus couldn't have capitalized on Muse the way Pfizer has Viagara. Leland is constantly behind the power curve in everything he does. It's always, too little too late. With the FDA inspection now completed and production ramping up, we will see what LELAND the incomp can do. RT